- Home
- RLAY vs ADEA Comparison
RLAY vs ADEA Comparison
Compare RLAY & ADEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | ADEA |
|---|---|---|
| Founded | 2015 | 1990 |
| Country | United States | United States |
| Employees | 197 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RLAY | ADEA |
|---|---|---|
| Price | $8.48 | $12.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | $16.00 | ★ $19.50 |
| AVG Volume (30 Days) | ★ 2.1M | 711.7K |
| Earning Date | 11-06-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 1.54% |
| EPS Growth | N/A | ★ 75.65 |
| EPS | N/A | ★ 0.65 |
| Revenue | $8,355,000.00 | ★ $379,912,000.00 |
| Revenue This Year | $20.47 | N/A |
| Revenue Next Year | N/A | $10.13 |
| P/E Ratio | ★ N/A | $20.00 |
| Revenue Growth | N/A | ★ 10.53 |
| 52 Week Low | $1.78 | $10.59 |
| 52 Week High | $9.04 | $18.25 |
Technical Indicators
Market Signals| Indicator | RLAY | ADEA |
|---|---|---|
| Relative Strength Index (RSI) | 64.38 | 43.64 |
| Support Level | $7.95 | $12.74 |
| Resistance Level | $9.04 | $13.23 |
| Average True Range (ATR) | 0.50 | 0.40 |
| MACD | 0.02 | 0.13 |
| Stochastic Oscillator | 69.06 | 32.43 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About ADEA Adeia Inc.
Adeia Inc is a consumer and entertainment product/solutions licensing company. Its only operating segment being Intellectual Property (IP) Licensing. In the IP segment, the company licenses innovations to companies in the broader entertainment industry, and those developing new technologies that will help drive this industry forward. It includes Pay-TV, Consumer Electronics, Connected Car, and Media Platform.